- Home
- RPTX vs FEIM Comparison
RPTX vs FEIM Comparison
Compare RPTX & FEIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPTX
- FEIM
- Stock Information
- Founded
- RPTX 2016
- FEIM 1961
- Country
- RPTX Canada
- FEIM United States
- Employees
- RPTX N/A
- FEIM N/A
- Industry
- RPTX Biotechnology: Pharmaceutical Preparations
- FEIM Electrical Products
- Sector
- RPTX Health Care
- FEIM Industrials
- Exchange
- RPTX Nasdaq
- FEIM Nasdaq
- Market Cap
- RPTX 69.2M
- FEIM 291.0M
- IPO Year
- RPTX 2020
- FEIM N/A
- Fundamental
- Price
- RPTX $1.72
- FEIM $30.98
- Analyst Decision
- RPTX Strong Buy
- FEIM
- Analyst Count
- RPTX 3
- FEIM 0
- Target Price
- RPTX $4.50
- FEIM N/A
- AVG Volume (30 Days)
- RPTX 96.5K
- FEIM 335.7K
- Earning Date
- RPTX 11-06-2025
- FEIM 09-11-2025
- Dividend Yield
- RPTX N/A
- FEIM N/A
- EPS Growth
- RPTX N/A
- FEIM 264.74
- EPS
- RPTX N/A
- FEIM 2.27
- Revenue
- RPTX $250,000.00
- FEIM $68,546,000.00
- Revenue This Year
- RPTX N/A
- FEIM $12.60
- Revenue Next Year
- RPTX N/A
- FEIM $19.17
- P/E Ratio
- RPTX N/A
- FEIM $12.17
- Revenue Growth
- RPTX N/A
- FEIM 18.30
- 52 Week Low
- RPTX $0.89
- FEIM $11.71
- 52 Week High
- RPTX $4.07
- FEIM $34.84
- Technical
- Relative Strength Index (RSI)
- RPTX 56.53
- FEIM 53.81
- Support Level
- RPTX $1.66
- FEIM $27.10
- Resistance Level
- RPTX $1.83
- FEIM $34.84
- Average True Range (ATR)
- RPTX 0.06
- FEIM 2.18
- MACD
- RPTX -0.00
- FEIM -0.59
- Stochastic Oscillator
- RPTX 52.00
- FEIM 53.42
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
About FEIM Frequency Electronics Inc.
Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.